BIRC2 and cancer: Since TRIM56 knockdown significantly downregulated cIAP1 expression and cIAP1 has been documented to play an oncogenic role in a variety of cancers, we hypothesized that cIAP1 may be a key molecule mediating the malignant function of TRIM56 in gliomas.